Understanding the molecular causes and risks of kidney and related diseases
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
This study is trying to understand the genetic and environmental factors that cause kidney diseases and their complications to help improve treatment and care for people at risk or already diagnosed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT05318196 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the molecular mechanisms that contribute to the development, progression, and complications of kidney diseases, including acute kidney injury and chronic kidney disease. By collecting biological samples from patients at risk or diagnosed with kidney-related conditions, the study seeks to identify genetic and environmental factors that influence disease outcomes. The research will also explore the impact of treatments and complications associated with solid-organ transplantation. Ultimately, the goal is to enhance risk stratification and improve patient management in nephrology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have kidney disease or are at risk of developing kidney disease.
Not a fit: Patients who are unable to provide consent or whose families cannot consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better risk assessment and personalized treatment strategies for patients with kidney diseases.
How similar studies have performed: Other studies have shown success in understanding molecular mechanisms in kidney diseases, but this specific approach may offer novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients (\> 18 year of age) with kidney disease or at risk to develop a kidney disease, * Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France) Exclusion Criteria: * consent deny * inability of the patient or its family to give consent.
Where this trial is running
Toulouse
- Rangueil University Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Stanislas Faguer, MD, PhD — University Hospital, Toulouse
- Study coordinator: Stanislas Faguer, MD, PhD
- Email: faguer.s@chu-toulouse.fr
- Phone: 561322475
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.